Beximco Pharmaceuticals Limited Goodwill

Beximco Pharmaceuticals Limited (BXP.L) currently reports a goodwill of $660M as of March 2026. That compares with $660M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Beximco Pharmaceuticals Limited's goodwill history and peer comparisons.

Beximco Pharmaceuticals Limited's goodwill was unchanged from $660M to $660M — essentially flat versus a year earlier (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Beximco Pharmaceuticals Limited reported $660M in goodwill as of March 2026. That compares with $660M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $660M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Beximco Pharmaceuticals Limited, and consider following BXP.L for alerts when major investors trade the stock.